Drug Neurology

Evrysdi

Payments companies reported to CMS as associated with Evrysdi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$920Kassociated payments (2023-2025)
892clinicians with associated payments
4companies reporting

By year

2023 $372K
2024 $308K
2025 $240K

Payments reported as associated with Evrysdi, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurology With Special Qualifications In Child Neurology $291K
Neurology (Psychiatry & Neurology) $224K
Neuromuscular Medicine (Psychiatry & Neurology) $216K
Nurse Practitioner $31K
Urology $30K
Physical Medicine & Rehabilitation $24K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Evrysdi

These are the largest totals companies reported as associated with Evrysdi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Perry Shieh Los Angeles, CA Neurology (Psychiatry & Neurology) $128,876.15
Shafeeq Ladha Phoenix, AZ Neuromuscular Medicine (Psychiatry & Neurology) $112,507.75
Omer Abdul Hamid Orlando, FL Neurology With Special Qualifications In Child Neurology $73,874.77
Shade Moody Houston, TX Neurology With Special Qualifications In Child Neurology $60,840.23
Manisha Korb West Palm Beach, FL Neuromuscular Medicine (Psychiatry & Neurology) $53,849.29
John Brandsema Philadelphia, PA Neurology With Special Qualifications In Child Neurology $36,203.75
Natan Bar-Chama New York, NY Urology $29,995.65
Michelle Gapay Stanford, CA Nurse Practitioner $27,733.55
Alexandra Montalvo Acevedo San Juan, PR Neuromuscular Medicine (Psychiatry & Neurology) $26,429.87
Louis Weimer New York, NY Neurology (Psychiatry & Neurology) $22,906.50

Prescribed Evrysdi?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.